Skip to main content
Premium Trial:

Request an Annual Quote

NHLBI Earmarks $1.2M over Three Years to Fund Short Courses in Genomics, Proteomics

NEW YORK, Aug. 15 (GenomeWeb News) - The National Heart, Lung, and Blood Institute is seeking applicants to develop short courses on the application of genomics and proteomics to heart, lung, blood, and sleep disorders.


NHLBI issued a request for applications for the program, entitled "Short Courses on Application of Genomics and Proteomics to Complex Heart, Lung, Blood, and Sleep Disorders," on Aug. 10.


The institute intends to spend around $1.2 million on the program through 2009, with $300,000 allocated for 2006. NHLBI said it expects to fund 1 or 2 grants under the program.


NHLBI said in the RFA that the courses "should provide hands-on training to investigators interested in leveraging genomic and proteomic technologies and resources to advance the understanding of disease mechanisms of interest to the institute."


Letters of intent are due on Dec. 19, and applications are due Jan. 17, 2006.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.